Cross Country Healthcare insider tax share withholding

Cross Country Healthcare’s General Counsel and Secretary, Susan E. Ball, reported an amended insider transaction reflecting tax withholding tied to restricted stock vesting.

Rhea-AI Filing Summary

Cross Country Healthcare’s General Counsel and Secretary, Susan E. Ball, reported an amended insider transaction reflecting tax withholding tied to restricted stock vesting. On March 31, 2025, multiple entries show shares of common stock withheld to cover tax obligations, including transactions of 1,740, 1,689, 2,015 and 3,942 shares at a price of $14.89 per share. These were coded as “F,” indicating shares withheld by the issuer rather than open-market sales. After these transactions, she directly beneficially owned 176,032 shares of Cross Country Healthcare common stock. The amendment corrects the transaction date originally reported as April 2, 2025, confirming that the activity occurred on March 31, 2025.

Insider Trade Summary

Exercise Price or Tax Liability: 9,386 shares

Exercise Price or Tax Liability 4 txns

Insider Ball Susan E

Role General Counsel and Secretary

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	1,740	$14.89	$26K
Exercise Price or Tax Liability	Common Stock	1,689	$14.89	$25K
Exercise Price or Tax Liability	Common Stock	2,015	$14.89	$30K
Exercise Price or Tax Liability	Common Stock	3,942	$14.89	$59K

Holdings After Transaction: Common Stock — 176,032 shares (Direct)

Footnotes (1)

1. F1. These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on March 31, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CCRN’s General Counsel report in this Form 4/A?

The General Counsel and Secretary, Susan E. Ball, reported shares of Cross Country Healthcare common stock being withheld to satisfy tax obligations related to restricted stock that vested on March 31, 2025.

Were the CCRN shares sold on the open market in this filing?

No. The transactions are coded “F” and the footnote explains that the shares were withheld to satisfy tax withholding obligations for restricted stock that vested on March 31, 2025, rather than open-market sales.

How many CCRN shares were withheld for taxes in the reported transactions?

The filing lists several tax-withholding entries at $14.89 per share, including 1,740, 1,689, 2,015 and 3,942 shares of Cross Country Healthcare common stock.

How many CCRN shares does Susan E. Ball own after these transactions?

Following the reported tax-withholding transactions, Susan E. Ball beneficially owns 176,032 shares of Cross Country Healthcare common stock in direct ownership.

What does the amendment in this Form 4/A for CCRN correct?

The amendment states that it corrects the transaction date of the reported transactions. It clarifies that the transactions occurred on March 31, 2025, instead of the original date referenced in the prior filing.

What role does the reporting person hold at Cross Country Healthcare (CCRN)?

The reporting person, Susan E. Ball, is identified as an officer of Cross Country Healthcare, serving as General Counsel and Secretary.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/12/2026 - 10:43 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ball Susan E

(Last) (First) (Middle)

C/O CROSS COUNTRY HEALTHCARE, INC.

6551 PARK OF COMMERCE BOULEVARD, N.W.

(Street)

BOCA RATON FL 33487

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CROSS COUNTRY HEALTHCARE INC [ CCRN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel and Secretary

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)
04/02/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/31/2025		F		1,740(1)	D	$14.89	183,678	D
Common Stock	03/31/2025		F		1,689(1)	D	$14.89	181,989	D
Common Stock	03/31/2025		F		2,015(1)	D	$14.89	179,974	D
Common Stock	03/31/2025		F		3,942(1)	D	$14.89	176,032	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on March 31, 2025.

Remarks:

This Form 4/A amends the Form 4 originally filed on April 2, 2025 to correct the transaction date of the transactions reported herein.

	/s/ Susan E. Ball	01/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.